Objective: Personalised Prevention of Pancreatic Cancer
|Núria Malats, MD, MPH, PhD,, Head of the Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain|
|Date: 16.12.2021 at 14:00 (CET)|
Meeting ID: 872 3661 8823
Identifying the population at high risk of developing non-hereditary pancreatic cancer in order to offer them to enter screening programs and diagnose cancer in early stages, is a must. To this end, we integrate information on the risk factors for this tumor with biomarkers determined at the omics level, including genomics and microbiome. All this information comes from a large study carried out in 28 centres from six European countries. For the integration of this big molecular data with epidemiological and clinical data, we use artificial intelligence tools. In the lecture, I will go through the most recent achievements of these collective efforts.